Novo Nordisk insulin finally approved in the US

Danish pharmaceutical giant has high hopes for products

The Danish pharmaceutical giant Novo Nordisk has announced that the US health authority, the FDA, has approved two of its products for the treatment of diabetes on the American market.

It has taken two years for the FDA to approve the two products, Tresiba and Ryzodeg, which help treat adults suffering from Type-1 and Type-2 diabetes.

“Since 1923, Novo Nordisk has been committed to advancing insulin therapy for patients with diabetes, and we are proud to bring forward the first new basal insulin molecule to be approved by the FDA in 10 years,” said Jesper Høiland, the president of Novo Nordisk in the US.

“Novo Nordisk is excited to launch Tresiba in the United States in the first quarter of 2016.”

READ MORE: Novo Nordisk to invest billions into US factory

Huge health issue
Novo Nordisk originally applied for approval on the US market in 2013, but the FDA was not convinced by the product, so the company undertook a clinical study regarding the risk of using the product.

The company has massive expectations for the US market and expects the products, already approved in Europe and Japan, to be among the leading diabetic products there within a few short years.

Over 29 million people are affected by diabetes in the US. Type 2 diabetes accounts for 90 to 95 percent of all diabetes cases. The number of Americans with diabetes has tripled over the past 30 years.

TOP STORIES

  • Chinese wind turbine companies sign pact to end race-to-the-bottom price war

    Chinese wind turbine companies sign pact to end race-to-the-bottom price war

    China’s 12 leading wind turbine makers have signed a pact to end a domestic price war that has seen turbines sold at below cost price in a race to corner the market and which has compromised quality and earnings in the sector.

  • Watch Novo Nordisk’s billion-kroner musical TV ad for Wegovy

    Watch Novo Nordisk’s billion-kroner musical TV ad for Wegovy

    Novo Nordisk’s TV commercial for the slimming drug Wegovy has been shown roughly 32,000 times and reached 8.8 billion US viewers since June.

  • Retention is the new attraction

    Retention is the new attraction

    Many people every year choose to move to Denmark and Denmark in turn spends a lot of money to attract and retain this international talent. Are they staying though? If they leave, do they go home or elsewhere? Looking at raw figures, we can see that Denmark is gradually becoming more international but not everyone is staying. 

  • Defence Minister: Great international interest in Danish military technology

    Defence Minister: Great international interest in Danish military technology

    Denmark’s Defence Minister Troels Lund Poulsen attended the Association of the Unites States Army’s annual expo in Washington DC from 14 to 16 October, together with some 20 Danish leading defence companies, where he says Danish drone technology attracted significant attention.

  • Doctors request opioids in smaller packs as over-prescription wakes abuse concerns

    Doctors request opioids in smaller packs as over-prescription wakes abuse concerns

    Doctors, pharmacies and politicians have voiced concern that the pharmaceutical industry’s inability to supply opioid prescriptions in smaller packets, and the resulting over-prescription of addictive morphine pills, could spur levels of opioid abuse in Denmark.

  • Housing in Copenhagen – it runs in the family

    Housing in Copenhagen – it runs in the family

    Residents of cooperative housing associations in Copenhagen and in Frederiksberg distribute vacant housing to their own family members to a large extent. More than one in six residents have either parents, siblings, adult children or other close family living in the same cooperative housing association.

Connect club

Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.

Sign up here

Career

  • Come and join us at Citizens Days!

    Come and join us at Citizens Days!

    On Friday 27 and Saturday 28 of September, The Copenhagen Post will be at International Citizen Days in Øksnehallen on Vesterbro, Copenhagen. Admission is free and thousands of internationals are expected to attend

  • Diversifying the Nordics: How a Nigerian economist became a beacon for inclusivity in Scandinavia

    Diversifying the Nordics: How a Nigerian economist became a beacon for inclusivity in Scandinavia

    Chisom Udeze, the founder of Diversify – a global organization that works at the intersection of inclusion, democracy, freedom, climate sustainability, justice, and belonging – shares how struggling to find a community in Norway motivated her to build a Nordic-wide professional network. We also hear from Dr. Poornima Luthra, Associate Professor at CBS, about how to address bias in the workplace.

  • Lolland Municipality launches support package for accompanying spouses

    Lolland Municipality launches support package for accompanying spouses

    Lolland Municipality, home to Denmark’s largest infrastructure project – the Fehmarnbelt tunnel connection to Germany – has launched a new jobseeker support package for the accompanying partners of international employees in the area. The job-to-partner package offers free tailored sessions on finding a job and starting a personal business.

Want to advertise your job with CPH Post?

Contact us

Jobs